Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Pharmacokinetics and Tolerability of Single-dose Staccato® Alprazolam in Adolescents with Epilepsy and Population PK Analysis to Support Dose Selection in Adolescents

              Author:Klein, Pavel   Aungaroon, Gewalin   Biton, Victor   Liow, Kore Kai   Phillips, Steven   Wychowski, Thomas   Sadek, Ahmed   Elshoff, Jan-Peer   Roebling, Robert   King, Aliceson   Ford, Andrea   Rospo, Chiara C   Schoemaker, Rik   Chanteux, Hugues   

              Session Name:P9: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Mechanisms, Pharmacokinetics, and Urgent Applications  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P9.002  

              Author Institution:Mid-atlantic Epilepsy and Sleep Center, Bethesda, MD  Cincinnati Children's Hospital Medical Center, Cincinnati, OH  Arkansas Epilepsy Program, Little Rock, AR  Hawaii Pacific Neuroscience, Honolulu, HI  MultiCare Institute for Research and Innovation, Tacoma, WA  University of Rochester Medical Center, Rochester, NY  Research Institute of Orlando, Orlando, FL  UCB Pharma, Monheim am Rhein, Germany  UCB Pharma, Smyrna, NC  Veramed, Twickenham, United Kingdom  UCB Pharma, Braine-l'Alleud, Belgium  Occams Cooperatie U.A., Amstelveen, Netherlands  UCB Pharma, Brussels, Belgium  

              Pharmacokinetics of Staccato® Alprazolam in Healthy Adult Participants: Phase 1, Randomized, Placebo-controlled Ethno-bridging Study

              Author:Roebling, Robert   Hayakawa, Yoshinobu   Rospo, Chiara C   Bartmann, Ana Paula   King, Aliceson   Chanteux, Hugues   

              Session Name:P9: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Mechanisms, Pharmacokinetics, and Urgent Applications  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P9.007  

              Author Institution:UCB Pharma, Monheim am Rhein, Germany  UCB Pharma, Tokyo, Japan  UCB Pharma, Braine l'Alleud, Belgium  UCB Pharma, Smyrna, GA  

              Pulmonary Safety of Staccato® Alprazolam in Healthy Participants and Participants with Mild Asthma: Phase 1, Randomized, Double-blind, Placebo-controlled Trial

              Author:Miller, S. David   LaForce, Craig F.   Barlow, Laura   King, Aliceson   Burian, Maria   Chanteux, Hugues   

              Session Name:P9: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Mechanisms, Pharmacokinetics, and Urgent Applications  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P9.009  

              Author Institution:Northeast Medical Research Associates, North Dartmouth, MA  North Carolina Clinical Research, Raleigh, NC  Veramed, Twickenham, United Kingdom  UCB Pharma, Smyrna, NC  UCB Pharma, Braine l'Alleud, Belgium